purchase agreement and/or relevant agreements and complete the transfer of BS Myco Biotech shares on June 12, 2019. This Acquisition is considered as the assets acquisition transaction of listed company and
sublease the Leased Property to One Sukhumvit 24. The Sublessor and One Sukhumvit 24 shall register the lease under the sublease agreement with respect to such land at the relevant land office within the end
-term land rental agreement, is considered to fit under the criteria of investment. In calculation of the transaction value the consolidated financial statement dated December 31, 2019 is being referenced
share purchase agreement with the Seller on 20 June 2018 (the “Share Purchase Agreement”). The material details and conditions of the Share Purchase Agreement are as follows: (1) The Company will directly
Listed Companies Concerning the Connected Transactions, 2003 (as amended) (“Notification on Connected Transaction”) Moreover, in 2016 the Company had entered into the Loan Agreement dated 29 February 2016
including event and concert organizing. The Transaction shall be subject to the completion of the conditions precedent under the share purchase agreement. After the Transaction completed, the Company will
capital of NEXT including event and concert organizing. The Transaction shall be subject to the completion of the conditions precedent under the share purchase agreement. After the Transaction completed
as from the date when the transaction disclosed to The Stock Exchange of Thailand. 4. Details of the Asset Acquired The Sole Area Development Franchise under Trademark “Wuttisak Clinic” in Eastern